After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccineTakeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – Share XAfter Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccinehttps://pharmaphorum.com/news/after-sanofis-setbacks-takeda-eyes-finish-line-with-its-dengue-vaccine/
Sanofi to pay back Philippines after Dengue vaccine problemsSanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, Share XSanofi to pay back Philippines after Dengue vaccine problemshttps://pharmaphorum.com/news/sanofi-reimburse-philippines-dengue-vaccine-scandal/
